Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4594475015 | Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4594476019 | Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Is a | Product containing only trilaciclib in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has precise active ingredient | Trilaciclib dihydrochloride | true | Inferred relationship | Some | 1 | |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Trilaciclib (substance) | true | Inferred relationship | Some | 1 | |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR